Risks of pharmaceutical supply chain disruptions from another pandemic or a Taiwan contingency are a growing concern, according to Minister Katsunobu Kato.
The global spread of the coronavirus has raised urgent concerns over the pharmaceutical sector’s excessive dependence on China. China produces many of the active...